Literature DB >> 7756065

Efficacy of a third coronary angioplasty for a second restenosis: short-term results, long-term follow up, and correlates of a third restenosis.

K H Tan1, N Sulke, N Taub, S Karani, E Sowton.   

Abstract

OBJECTIVE: To report on the short-term and long-term results of patients who underwent a third coronary balloon angioplasty for a second restenosis and to identify the correlates of a third clinical restenosis.
DESIGN: A retrospective analysis of clinical, angiographic, and procedure related variables of a consecutive series of patients. PATIENTS: 62 patients (mean (range) age 53 (31-72) years; 84% men) who underwent a third coronary balloon angioplasty of a single coronary artery segment at which restenosis had occurred after two previous angioplasty procedures between 1986 and 1992.
RESULTS: Procedure success was achieved in 56 patients (90%). Complications included one myocardial infarction (2%) and one emergency coronary artery bypass surgery (2%). Complete follow up data were available (median (range) 48 (12-94) months). During the follow up period, four patients (6%) died, two (3%) had a non-fatal myocardial infarction, and five (8%) underwent elective coronary artery bypass surgery. Nine patients (14%) underwent a fourth angioplasty for a third clinical restenosis, and three (5%) had a fourth angioplasty procedure for new coronary lesions. The cumulative probability of survival for all 62 patients was 97% and 95% at 1 and 5 years, respectively. The 1 and 5 year freedom from death, infarction, bypass surgery, and repeat angioplasty was 82% and 66.6%, respectively. At census, of the 58 survivors, 31 (53%) were asymptomatic and only eight (14%) complained of angina grade III or IV (P < 0.001). A third clinical restenosis occurred in 22 (39%) of the 56 patients who had initially successful procedures. Multiple stepwise logistic regression analysis identified the interval between the second and third angioplasty procedure as the only independent predictor of a third clinical restenosis (P = 0.004).
CONCLUSIONS: A third coronary angioplasty for a second restenosis can be performed safely and effectively and should be considered as an integral part of the overall coronary angioplasty revascularisation strategy. The incidence of a third clinical restenosis remains high, however, and is correlated with the interval between the previous angioplasty procedures.

Entities:  

Mesh:

Year:  1995        PMID: 7756065      PMCID: PMC483825          DOI: 10.1136/hrt.73.4.327

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  23 in total

1.  Repeat coronary angioplasty for restenosis: results and predictors of follow-up clinical events.

Authors:  U Deligonul; M Vandormael; M J Kern; K Galan
Journal:  Am Heart J       Date:  1989-05       Impact factor: 4.749

2.  Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty.

Authors:  J J Glazier; T R Varricchione; T J Ryan; N A Ruocco; A K Jacobs; D P Faxon
Journal:  Br Heart J       Date:  1989-06

Review 3.  Lesion morphology and coronary angioplasty: current experience and analysis.

Authors:  R K Myler; R E Shaw; S H Stertzer; H S Hecht; C Ryan; J Rosenblum; D C Cumberland; M C Murphy; H N Hansell; B Hidalgo
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

4.  Repeat coronary angioplasty: correlates of a second restenosis.

Authors:  A J Black; H V Anderson; G S Roubin; S W Powelson; J S Douglas; S B King
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

5.  Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

Authors:  S G Ellis; M G Vandormael; M J Cowley; G DiSciascio; U Deligonul; E J Topol; T M Bulle
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

6.  Treatment of recurrent restenosis with repeat percutaneous transluminal coronary angioplasty.

Authors:  P Joly; R Bonan; D Palisaitis; A Cequier; J Crépeau; G Coté; P De Guise; D D Waters
Journal:  Am J Cardiol       Date:  1988-04-15       Impact factor: 2.778

7.  Repeat coronary angioplasty as treatment for restenosis.

Authors:  A P Dimas; F Grigera; R R Arora; C C Simpfendorfer; J L Hollman; J H Frierson; I Franco; P L Whitlow
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

8.  A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group.

Authors:  E J Topol; F Leya; C A Pinkerton; P L Whitlow; B Hofling; C A Simonton; R R Masden; P W Serruys; M B Leon; D O Williams
Journal:  N Engl J Med       Date:  1993-07-22       Impact factor: 91.245

9.  Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis.

Authors:  P J Quigley; M A Hlatky; T Hinohara; D S Rendall; J A Perez; H R Phillips; R M Califf; R S Stack
Journal:  Am J Cardiol       Date:  1989-02-15       Impact factor: 2.778

10.  Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty.

Authors:  J J Glazier; T R Varricchione; T J Ryan; N A Ruocco; A K Jacobs; D P Faxon
Journal:  Am J Cardiol       Date:  1989-04-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.